- Home
- PTIX vs BACK Comparison
PTIX vs BACK Comparison
Compare PTIX & BACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTIX
- BACK
- Stock Information
- Founded
- PTIX 1994
- BACK 2000
- Country
- PTIX United States
- BACK United States
- Employees
- PTIX N/A
- BACK N/A
- Industry
- PTIX Biotechnology: Pharmaceutical Preparations
- BACK Medical Specialities
- Sector
- PTIX Health Care
- BACK Health Care
- Exchange
- PTIX Nasdaq
- BACK Nasdaq
- Market Cap
- PTIX 2.0M
- BACK 1.6M
- IPO Year
- PTIX 2016
- BACK 2019
- Fundamental
- Price
- PTIX $0.27
- BACK $0.66
- Analyst Decision
- PTIX
- BACK
- Analyst Count
- PTIX 0
- BACK 0
- Target Price
- PTIX N/A
- BACK N/A
- AVG Volume (30 Days)
- PTIX 599.7K
- BACK 4.2M
- Earning Date
- PTIX 03-31-2025
- BACK 04-15-2025
- Dividend Yield
- PTIX N/A
- BACK N/A
- EPS Growth
- PTIX N/A
- BACK N/A
- EPS
- PTIX N/A
- BACK N/A
- Revenue
- PTIX N/A
- BACK $72,050.00
- Revenue This Year
- PTIX N/A
- BACK N/A
- Revenue Next Year
- PTIX N/A
- BACK N/A
- P/E Ratio
- PTIX N/A
- BACK N/A
- Revenue Growth
- PTIX N/A
- BACK N/A
- 52 Week Low
- PTIX $0.25
- BACK $0.47
- 52 Week High
- PTIX $1.87
- BACK $7.75
- Technical
- Relative Strength Index (RSI)
- PTIX 34.94
- BACK 42.28
- Support Level
- PTIX $0.25
- BACK $0.50
- Resistance Level
- PTIX $0.30
- BACK $0.76
- Average True Range (ATR)
- PTIX 0.03
- BACK 0.11
- MACD
- PTIX 0.00
- BACK 0.02
- Stochastic Oscillator
- PTIX 10.43
- BACK 43.33
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
About BACK IMAC Holdings Inc.
IMAC Holdings Inc is a provider and manager of value-based, conservative medical care combining life science advancements with traditional medical care for movement-restricting diseases and conditions in IMAC Regeneration Centers and BackSpace clinics. Its Innovative Medical Advancements and Care (IMAC) Regeneration Centers combine medical and physical procedures to improve patient experiences and outcomes and reduce healthcare costs as compared to other available treatment options.